Viewing Study NCT05513560


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 4:54 AM
Study NCT ID: NCT05513560
Status: SUSPENDED
Last Update Posted: 2025-08-15
First Post: 2022-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
Sponsor: University Health Network, Toronto
Organization:

Study Overview

Official Title: REcovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine (RECLAIM)
Status: SUSPENDED
Status Verified Date: 2025-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: We are analyzing data for efficacy
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RECLAIM
Brief Summary: The researchers propose to develop a Canada-wide, adaptive randomized clinical platform trial to assess the effectiveness of various interventions in patients with lingering symptoms of COVID-19 ("Long COVID"). Participants will be randomized initially to 1 of 3 arms, including placebo (control) and 2 interventions. Because this is an adaptive trial, arms can be dropped if found to be ineffective and new arms can be added.

Interventions will last for 2 months and participants will be followed for an additional 4 months (6 months total). Approximately 800-1000 patients with Long COVID will be recruited across Canada. Results from this trial will accelerate the availability of high-quality, real-time evidence and solutions to enable Canada to improve the clinical care of patients with Long COVID.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: